Mayar Capital Ltd. Has $12.54 Million Stock Position in Kenvue Inc. $KVUE

Mayar Capital Ltd. lifted its stake in Kenvue Inc. (NYSE:KVUE) by 56.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 726,716 shares of the company’s stock after acquiring an additional 262,000 shares during the period. Kenvue accounts for about 17.0% of Mayar Capital Ltd.’s investment portfolio, making the stock its largest position. Mayar Capital Ltd.’s holdings in Kenvue were worth $12,536,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC boosted its stake in Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after buying an additional 1,361 shares in the last quarter. NBT Bank N A NY raised its stake in shares of Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares in the last quarter. Salomon & Ludwin LLC bought a new position in shares of Kenvue during the 3rd quarter worth about $25,000. Golden State Wealth Management LLC lifted its holdings in shares of Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after acquiring an additional 1,190 shares during the period. Finally, Trust Co. of Vermont grew its holdings in shares of Kenvue by 50.9% during the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Barclays reduced their price objective on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research report on Wednesday, April 8th. Citigroup reduced their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Argus raised shares of Kenvue to a “hold” rating in a research note on Friday, March 6th. Finally, Jefferies Financial Group lowered shares of Kenvue from a “buy” rating to a “hold” rating and cut their target price for the stock from $23.00 to $18.00 in a report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and an average price target of $19.33.

Kenvue Trading Down 0.0%

Shares of NYSE:KVUE opened at $17.61 on Monday. The firm has a market cap of $33.80 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 4.00 and a beta of 0.61. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The company’s fifty day simple moving average is $17.92 and its 200 day simple moving average is $17.11. The company has a quick ratio of 0.68, a current ratio of 0.96 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. During the same quarter in the prior year, the company earned $0.26 EPS. The company’s revenue was up 3.2% on a year-over-year basis. As a group, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is currently 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.